Premium
Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost
Author(s) -
Bernard L.,
Pron B.,
Lotthé A.,
Gleizes V.,
Signoret F.,
Denormandie Ph.,
Gaillard J. L.,
Perronne C.
Publication year - 2001
Publication title -
journal of clinical pharmacy and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 73
eISSN - 1365-2710
pISSN - 0269-4727
DOI - 10.1046/j.1365-2710.2001.00380.x
Subject(s) - medicine , antimicrobial , osteomyelitis , intensive care medicine , surgery , organic chemistry , chemistry
Objectives: To evaluate the feasibility, efficacy, and cost of outpatient parenteral antimicrobial therapy (OPAT) in the treatment of osteomyelitis. Subjects: 39 patients with an osteomyelitis requiring parenterally administered antibiotics for more than 4 weeks, and able to receive antibiotics at home. Methods: All patients had a totally implanted catheter. Antibiotics were administered by continuous infusion using a portable elastomeric infusion system, which was changed every day by the patient or by the home‐care nurse. Laboratory monitoring and surveillance were performed weekly. Clinical efficacy, adverse effects and quality of life were recorded. Results: The most commonly used antibiotics were vancomycin (51%) and β‐lactam (44%) antibiotics. Thirty patients were available for follow‐up for a minimum of 12 months after completion of therapy. Twenty‐eight (93%) were considered cured of their infection with a mean of 24 ± 4 months after completion of antibiotic therapy. Adverse effects among the study patients were rare. The 39 patients in our OPAT programme resulted in a potential saving of US $1 873 885 relative to conventional therapy. Conclusion: OPAT is practicable and effective and may be the best alternative treatment for patients suffering from osteomyelitis requiring intravenous therapy.